New incretin-based medicines will allow weight, diabetes control with a single weekly dose
The new generation of incretin-based medicines will allow a coordinated action against the combination diabetes/obesity, also known as diabesity, in some cases with only a single weekly dose, and with the likelihood of additional beneficial effects on other health complications related to this condition, such as cardiovascular and neurodegenerative diseases.
Source: ScienceDaily Headlines - Category: Science Source Type: news
More News: Cardiology | Cardiovascular | Diabetes | Eating Disorders & Weight Management | Endocrinology | Health | Heart | Incretin Therapy | Neurology | Obesity | Science